The Procter & Gamble Company (NYSE:PG – Free Report) – William Blair reduced their Q2 2025 earnings estimates for Procter & Gamble in a note issued to investors on Monday, November 25th. William Blair analyst J. Andersen now anticipates that the company will post earnings of $1.90 per share for the quarter, down from their prior forecast of $1.92. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.96 per share. William Blair also issued estimates for Procter & Gamble’s Q4 2025 earnings at $1.54 EPS.
Other equities research analysts also recently issued research reports about the stock. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price for the company. in a research note on Monday, September 30th. Morgan Stanley upped their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $160.00 to $209.00 in a research report on Monday. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Procter & Gamble Trading Up 0.0 %
Shares of NYSE PG opened at $179.34 on Wednesday. Procter & Gamble has a fifty-two week low of $142.50 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market capitalization of $422.35 billion, a P/E ratio of 30.92, a P/E/G ratio of 3.82 and a beta of 0.42. The company’s 50 day simple moving average is $170.22 and its 200 day simple moving average is $168.90.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the business earned $1.83 earnings per share. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis.
Institutional Trading of Procter & Gamble
Large investors have recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC lifted its stake in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after buying an additional 4,035 shares during the last quarter. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth about $5,705,000. Welch Group LLC lifted its stake in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after buying an additional 2,990 shares during the last quarter. Swiss National Bank lifted its stake in shares of Procter & Gamble by 0.6% during the 3rd quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock worth $1,213,403,000 after buying an additional 39,000 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares in the company, valued at $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock worth $6,024,234 over the last quarter. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing in the High PE Growth Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Dividend Capture Strategy: What You Need to Know
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.